Literature DB >> 2513461

Endothelium-derived relaxing factor (nitric oxide) has protective actions in the stomach.

W K MacNaughton1, G Cirino, J L Wallace.   

Abstract

The role that nitric oxide, an endothelium-derived relaxing factor, may play in the regulation of gastric mucosal defence was investigated by assessing the potential protective actions of this factor against the damage caused by ethanol in an ex vivo chamber preparation of the rat stomach. Topical application of glyceryl trinitrate and sodium nitroprusside, which have been shown to release nitric oxide, markedly reduced the area of 70% ethanol-induced hemorrhagic damage. Topical application of a 0.01% solution of authentic nitric oxide also significantly reduced the severity of mucosal damage. Pretreatment with indomethacin precluded the involvement of endogenous prostaglandins in the protective effects of these agents. The protective effects of NO were transient, since a delay of 5 minutes between NO administration and ethanol administration resulted in a complete loss of the protective activity. The protection against ethanol afforded by 10 micrograms/ml nitroprusside could be completely reversed by intravenous infusion of either 1% methylene blue or 1 mM hemoglobin, both of which inhibit vasodilation induced by nitric oxide. Intravenous infusion of 1% methylene blue significantly increased the susceptibility of the mucosa to damage induced by topical 20% ethanol. These results indicate that ethanol-induced gastric damage can be significantly reduced by nitric oxide. The mechanisms underlying the protective actions of nitric oxide are unclear, but may be related to its vasodilator or anti-aggregatory properties.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2513461     DOI: 10.1016/0024-3205(89)90540-7

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  48 in total

1.  Bleeding duodenal ulcer and association with polymorphism of endothelial constitutive nitric oxide synthase gene.

Authors:  Trinidad Serrano; Elena Piazuelo; Rafael Benito; Santos Santolaria; Angel Lanas
Journal:  Dig Dis Sci       Date:  2002-05       Impact factor: 3.199

2.  Role of L-arginine, a substrate for nitric oxide-synthase, in gastroprotection and ulcer healing.

Authors:  T Brzozowski; S J Konturek; Z Sliwowski; D Drozdowicz; M Zaczek; D Kedra
Journal:  J Gastroenterol       Date:  1997-08       Impact factor: 7.527

Review 3.  Building a better aspirin: gaseous solutions to a century-old problem.

Authors:  J L Wallace
Journal:  Br J Pharmacol       Date:  2007-07-16       Impact factor: 8.739

Review 4.  Risk factors for gastrointestinal complications in aspirin users: review of clinical and experimental data.

Authors:  Felix W Leung
Journal:  Dig Dis Sci       Date:  2008-02-28       Impact factor: 3.199

5.  Mechanisms of gastroprotection by transdermal nitroglycerin in the rat.

Authors:  S Calatayud; M J Sanz; A Canet; R Bello; F D de Rojas; J V Esplugues
Journal:  Br J Pharmacol       Date:  1999-07       Impact factor: 8.739

Review 6.  Pathologic basis of gastric mucosal adaptation to topical injury.

Authors:  J Stachura; S J Konturek; T Brzozowski; J Konturek; W Domschke
Journal:  J Gastroenterol       Date:  1995-06       Impact factor: 7.527

Review 7.  Mechanisms, prevention and clinical implications of nonsteroidal anti-inflammatory drug-enteropathy.

Authors:  John L Wallace
Journal:  World J Gastroenterol       Date:  2013-03-28       Impact factor: 5.742

8.  Acute normovolaemic anaemia prevents ethanol-induced gastric damage in rats through a blood flow related mechanism.

Authors:  M Casadevall; J M Piqué; I Cirera; M D Barrachina; J Terés
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

Review 9.  Nitric oxide in the gastrointestinal tract: opportunities for drug development.

Authors:  John L Wallace
Journal:  Br J Pharmacol       Date:  2018-12-03       Impact factor: 8.739

10.  Experimental colitis is ameliorated by inhibition of nitric oxide synthase activity.

Authors:  D Rachmilewitz; F Karmeli; E Okon; M Bursztyn
Journal:  Gut       Date:  1995-08       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.